432 related articles for article (PubMed ID: 12743325)
1. In utero hematopoietic stem cell transplantation in nonhuman primates: the role of T cells.
Shields LE; Gaur LK; Gough M; Potter J; Sieverkropp A; Andrews RG
Stem Cells; 2003; 21(3):304-14. PubMed ID: 12743325
[TBL] [Abstract][Full Text] [Related]
2. Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates.
Shields LE; Gaur L; Delio P; Potter J; Sieverkropp A; Andrews RG
Stem Cells; 2004; 22(5):759-69. PubMed ID: 15342940
[TBL] [Abstract][Full Text] [Related]
3. The use of CD 34(+) mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in non-human primates.
Shields LE; Gaur L; Delio P; Gough M; Potter J; Sieverkropp A; Andrews RG
J Med Primatol; 2005 Aug; 34(4):201-8. PubMed ID: 16053498
[TBL] [Abstract][Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
5. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.
Hayashi S; Hsieh M; Peranteau WH; Ashizuka S; Flake AW
Exp Hematol; 2004 Mar; 32(3):290-9. PubMed ID: 15003315
[TBL] [Abstract][Full Text] [Related]
6. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E
Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658
[TBL] [Abstract][Full Text] [Related]
7. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Masmas TN; Dickmeiss E; Heilmann C; Vindeløv LL
Biol Blood Marrow Transplant; 2004 May; 10(5):337-46. PubMed ID: 15111933
[TBL] [Abstract][Full Text] [Related]
8. Stable multilineage chimerism across full MHC barriers without graft-versus-host disease following in utero bone marrow transplantation in pigs.
Lee PW; Cina RA; Randolph MA; Goodrich J; Rowland H; Arellano R; Kim HB; Sachs DH; Huang CA
Exp Hematol; 2005 Mar; 33(3):371-9. PubMed ID: 15730861
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation in utero produces sheep-goat chimeras.
Oppenheim SM; Muench MO; Gutiérrez-Adán A; Moyer AL; BonDurant RH; Rowe JD; Anderson GB
Blood Cells Mol Dis; 2001; 27(1):296-308. PubMed ID: 11358392
[TBL] [Abstract][Full Text] [Related]
10. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic chimerism in sheep and nonhuman primates by in utero transplantation of fetal hematopoietic stem cells.
Zanjani ED; Mackintosh FR; Harrison MR
Blood Cells; 1991; 17(2):349-63; discussion 364-6. PubMed ID: 1680504
[TBL] [Abstract][Full Text] [Related]
12. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
Bhattacharyya S; Cowan MJ
Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
[TBL] [Abstract][Full Text] [Related]
13. Use of T-cell antibodies for donor dosaging in a canine model of in utero hematopoietic stem cell transplantation.
Petersen SM; Gendelman M; Murphy KM; Torbenson M; Jones RJ; Althaus JE; Stetten G; Bird C; Blakemore KJ
Fetal Diagn Ther; 2007; 22(3):175-9. PubMed ID: 17228153
[TBL] [Abstract][Full Text] [Related]
14. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H
Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815
[TBL] [Abstract][Full Text] [Related]
15. In utero hematopoietic stem cell transplantation with haploidentical donor adult bone marrow in a canine model.
Blakemore K; Hattenburg C; Stetten G; Berg K; South S; Murphy K; Jones R
Am J Obstet Gynecol; 2004 Apr; 190(4):960-73. PubMed ID: 15118622
[TBL] [Abstract][Full Text] [Related]
16. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation.
Wu BY; Guo KY; Song CY; Yang ; Li D
Bone Marrow Transplant; 2000 Sep; 26(6):691-3. PubMed ID: 11035376
[TBL] [Abstract][Full Text] [Related]
17. Mixed chimerism is frequent after allogeneic peripheral blood stem cell transplantation with positive CD34 selection, and is not reverted by low doses of donor T-cells add-back.
Rodríguez-Luaces M; Ferrá C; Martín-Henao G; Berlanga JJ; Grañena A; Gallardo D
Eur J Haematol; 2004 Sep; 73(3):162-8. PubMed ID: 15287912
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.
Boeck S; Hamann M; Pihusch V; Heller T; Diem H; Rolf B; Pihusch R; Kolb HJ; Pihusch M
Bone Marrow Transplant; 2006 Jan; 37(1):57-64. PubMed ID: 16258529
[TBL] [Abstract][Full Text] [Related]
19. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
[TBL] [Abstract][Full Text] [Related]
20. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR
Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
